Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry

Antonini, Angelo; Poewe, Werner; Chaudhuri, K Ray; Jech, Robert; Pickut, Barbara; Pirtošek, Zvezdan; Szasz, Jozsef; Valldeoriola, Francesc; Winkler, Christian; Bergmann, Lars; Yegin, Ashley; Onuk, Koray; Barch, David; Odin, Per; Burkhard, Pierre

doi:10.1016/j.parkreldis.2017.09.018

Scientific article

English

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry

ContributorsAntonini, Angelo; Poewe, Werner; Chaudhuri, K Ray; Jech, Robert; Pickut, Barbara; Pirtošek, Zvezdan; Szasz, Jozsef; Valldeoriola, Francesc; Winkler, Christian; Bergmann, Lars; Yegin, Ashley; Onuk, Koray; Barch, David; Odin, Per; Burkhard, Pierre

Published inParkinsonism & Related Disorders, vol. 45, p. 13-20

Publication date2017

Abstract

This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intestinal gel (LCIG) treatment in advanced Parkinson's disease (PD) patients under routine clinical care.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département des neurosciences cliniques

Research groups

Groupe Pierre Burkhard (neurologie) (154)

Citation (ISO format)

ANTONINI, Angelo et al. Levodopa-carbidopa intestinal gel in advanced Parkinson’s: Final results of the GLORIA registry. In: Parkinsonism & Related Disorders, 2017, vol. 45, p. 13–20. doi: 10.1016/j.parkreldis.2017.09.018

Article (Published version)

Identifiers

PID : unige:98452
DOI : 10.1016/j.parkreldis.2017.09.018
PMID : 29037498

Journal ISSN1353-8020

653views

0downloads

Creation20/10/2017 12:47:00

First validation20/10/2017 12:47:00

Update15/03/2023 02:15:12

Status update15/03/2023 02:15:11

Last indexation31/10/2024 08:22:21

Archive ouverte UNIGE

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry

This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intestinal gel (LCIG) treatment in advanced Parkinson's disease (PD) patients under routine clinical care.

Technical informations